Hyperliquid’s Billion-Dollar Gambit: A SPAC Odyssey 🤑🚀
This union, announced with all the fanfare of a minor royal engagement, is expected to culminate by year’s end. The resulting entity, a chimera of biotech and finance, will prance onto Nasdaq under a new ticker symbol, no doubt to the delight of day traders and the bewilderment of the rest of us. At the helm of this ship of fools are Chairman Bob Diamond, erstwhile overlord of Barclays, and CEO David Schamis, a man who clearly relishes the sound of his own voice.



